Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

January 25, 2024

Study Completion Date

January 25, 2024

Conditions

Atopic DermatitisDermatitis Atopic

Interventions

DRUG

Dupilumab

Dupilumab solution in a pre-filled syringe for Subcutaneous injection

Trial Locations (1)

Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital), Guangzhou